09/01/2026
Comment "MATRIX" for my free masterclass on applying the Matrix Medicine framework in clinical practice.
For many people, Lyme is treated and resolved. But a subset stay sick long after treatment, and the usual explanations are lingering bacteria or permanent damage. There's a third factor most protocols miss: the terrain the infection remodeled and left behind.
Borrelia doesn't just infect. It anchors into the extracellular matrix by binding decorin, a core building block of connective tissue in joints, nerves, and skin. It borrows your own enzymes to remodel that matrix, and builds biofilm using your body's own matrix material as scaffolding. The result is a congested, biofilm-laden terrain that shelters the pathogen and blunts the immune response.
A striking mouse study shows why this matters. Researchers infected mice with Borrelia that either could or couldn't bind decorin, then treated all of them with antibiotics. The decorin-binding strain left borrelial DNA persisting in the joints for weeks after treatment. The strain that couldn't bind the matrix showed no such persistence. Anchoring into the terrain was what allowed the bacteria to persist after appropriate antibiotics.
An honest note: this is a mouse model, and decorin binding promotes matrix persistence rather than being the only route, since Borrelia can also invade collagen directly. But the principle holds. The matrix is part of why some Lyme cases don't clear.
This is why terrain belongs in Lyme care. Open drainage, restore oxygen, support the matrix, disrupt the biofilm. Then the treatment can reach its target and the immune system can finish the job.
Drain the terrain. Disrupt the biofilm. Then drive the treatment.
Reference: Salo J, et al. Decorin Binding Proteins of Borrelia burgdorferi Promote Arthritis Development and Joint-Specific Post-Treatment DNA Persistence in Mice. PLoS One. 2015. PMC4376631.
Comment "MATRIX" for the free masterclass on Matrix physiology.